the free levels were normal in patients with liver disease despite low total levels and that free levels were elevated in pregnant women in the third trimester more that would be predicted based on total levels. 
Introduction
Circulating levels of 25-hydroxyvitamin D (25(OH)D) are the most commonly used marker for the assessment of vitamin D nutritional status. This is because its concentration in blood is higher than all other vitamin D metabolites, making it easier to measure, and because its conversion from vitamin D is substrate dependent with minimal regulation. The liver is the major source of this conversion, performed by a number of enzymes with 25-hydroxylase activity, the most specific of which is CYP2R1. However, 25OHD is not the most biologically 
Vitamin D production and metabolism

Vitamin D Production
Vitamin D 3 (D 3 ) (cholecalciferol) is produced from 7-dehydrocholesterol (7-DHC) in the skin through a two-step process in which the B ring is broken by ultraviolet light (UVB spectrum 280-320nm), forming pre-D 3 that isomerizes to D 3 in a thermo-sensitive but non catalytic process. Vitamin D is also obtained from the diet. Most foods with the exception of fatty fish contain little vitamin D unless fortified. The vitamin D in fish is D 3 , whereas that used for fortification is often D 2 (ergocalciferol). D 2 is produced by UVB irradiation of ergosterol in plants and fungi (eg. mushrooms). It differs from D 3 in having a double bond between C22-C23 and a methyl group at C24 in the side chain. These differences from D 3 in the side chain lower its affinity for DBP resulting in a higher ratio of free to total vitamin D metabolite concentration as well as faster clearance from the circulation and altered catabolism by the 24-hydroxyase (CYP24A1) [2] [3] [4] . Moreover, a number of immunoassays do not recognize the D 2 metabolites as well as the D 3 metabolites, a problem to which we will return. However, the biologic activity of D 2 and D 3 metabolites are comparable, and if no subscript is used, both forms are meant.
Vitamin D Metabolism
The three main steps in vitamin D metabolism, 25-hydroxylation, 1α-hydroxylation, and 24-hydroxylation are all performed by cytochrome P450 mixed function oxidases (CYPs) located either in the endoplasmic reticulum (ER) (eg. CYP2R1) or in the mitochondrion (eg.CYP27A1, CYP27B1 and CYP24A1).
25-hydroxylase.
The liver is the major if not sole source of 25(OH)D production. There are multiple 25-hydroxyases, but the best studied are CYP27A1 and CYP2R1. CYP27A1 is the only mitochondrial 25-hydroxylase. It was initially identified as a sterol 27-hydroxylase involved in bile acid synthesis and so is not specific for vitamin D. Moreover, it preferentially hydroxylates D 3 vs D 2 . It is widely distributed in the body, not just in the liver. Its relevance to vitamin D metabolism is unclear since its deletion in mice results in increased blood levels of 25(OH)D [5] , and inactivating mutations in humans cause cerebrotendinous xanthomatosis not rickets [6] .
CYP2R1 is in the microsomal fraction [7] , with distribution primarily limited to the liver and testes. It 25-hydroxylates both D 2 and D 3 with comparable kinetics. Deletion of CYP2R1 reduces blood levels of 25OHD by 50%, but not to zero [8] suggesting compensation by other enzymes with 25-hydroxylase activity. However, inactivating mutations in CYP2R1 have been found in humans presenting with rickets [9] . Thus, CYP2R1 is considered the major albeit not the only 25-hydroxylase contributing to circulating levels of 25(OH)D. Regulation of vitamin D 25- hydroxylation is modest at best with production being primarily substrate dependent such that circulating levels of 25(OH)D are a useful marker of vitamin D nutrition.
25(OH)D 1α-hydroxylase (CYP27B1).
CYP27B1 is the only known 25(OH)D 1-hydroxylase. Although the kidney is the main source of circulating 1,25(OH) 2 D, a number of other tissues also express the enzyme. As we will discuss subsequently, most tissues expressing CYP27B1 rely on the free 25OHD level in blood for their available substrate, whereas the kidney tubule has a mechanism for taking up 25OHD still bound to its major binding protein, vitamin D binding protein (DBP). Moreover, regulation of the extrarenal CYP27B1 differs from that of the renal CYP27B1 (review in [10] ). The renal 1α-hydroxylase is tightly regulated primarily by three hormones: parathyroid hormone (PTH) (stimulatory), FGF23
(inhibitory), and 1,25(OH 2 D itself (inhibitory). CYP27B1 activity in extrarenal tissues is not regulated by PTH and FGF23, but at least in epidermal keratinocytes and cells of the immune system the regulation is by cytokines such as tumor necrosis factor-α (TNFa) and interferon-γ (IFNg) [11 12] [13] . In these tissues as well as in the kidney 1,25(OH) 2 D induces CYP24A1, the 24-hydroxylase, that catabolizes both 25OHD and 1,25(OH 2 D. This is the major mechanism controlling 1,25(OH) 2 D levels in these cells. As for 25(OH)D, it is anticipated that it is the free concentration of 1,25(OH) 2 D that enters most cells, the kidney proximal tubule, parathyroid gland, and placenta being likely exceptions as will be discussed. other cancers, the expression of CYP24A1 in melanoma is inversely correlated with melanoma progression [16] . Thus, it is incorrect to consider the 24-hydroxylase as purely a catabolic enzyme for 25(OH)D and 1,25(OH) 2 D. All steps are performed by one enzyme [17] . Regulation of CYP24A1 is the reciprocal of that of CYP27B1 at least in the kidney in that PTH inhibits but FGF23 stimulates its expression.
24-hydroxylase (CYP24A1
The free hormone hypothesis (figure 1).
The hypothesis and its modification
The free hormone hypothesis postulates that only the non bound fraction (the free fraction) of hormones that otherwise circulate in blood bound to their carrier proteins is able to enter cells and exert their biologic effects. Examples include the vitamin D metabolites, about which we are concerned in this review, sex steroids, cortisol, and thyroid hormone. These are lipophilic hormones assumed to cross the plasma membrane by diffusion and not by an active transport mechanism. However, the free hormone concentration is not the only factor involved with the rate at which the hormone enters the cells. As articulated by Mendel [18] , movement of hormone into the cell in vivo is dependent not only on the free concentration but also on the dissociation of hormone from its binding protein, the rate of blood flow, the rate of uptake into the cell, and the catabolism/sequestration of hormone within the cell. These are components of the transport process that Mendel calls the free hormone transport process. Thus, the total concentration of hormone, by affecting the total amount of free hormone available to the cell, does influence the extent of transport of hormone into the cell when the rate of transport is not rate limiting. That said, our knowledge of most of these variables is limited, so our focus in this review will be on the free hormone itself, its measurement, and what influences this fraction of the total hormone in circulation.
Development of the hypothesis.
One of the earliest articulations of the free hormone hypothesis was published by Recant and Riggs [19] when they examined thyroid function in patients with protein losing nephropathy.
They noted that circulating thyroid hormone (measured as protein bound iodine or PBI) was quite low in these patients along with increased urinary losses but with relatively little evidence for clinical hypothyroidism. They concluded that "thyroid function and the supply of hormone to the tissues in nephrosis may be normal, and that the low concentration of protein-bound iodine in the plasma is due to the change in concentration or binding capacity of the plasma proteins in nephrosis". Subsequent studies have established the free hormone hypothesis for the thyroid and steroid hormones [20 21] . Similar conclusions regarding the importance of the free levels of vitamin D metabolites came initially from observations that the increase in 1,25(OH) 2 D levels with administration of oral contraceptives or during the third trimester of pregnancy was not associated with changes in calcium metabolism, at least until the latter stages of pregnancy, but was accompanied by a parallel increase in DBP [22] . This role of DBP as carrier of the vitamin D metabolites was well demonstrated in mice in which the DBP gene was deleted. Although these mice lost substantial amounts of the vitamin D metabolites in the urine, and their circulating levels of 25(OH) D were very low, they did not develop evidence of rickets until put on a low vitamin D diet [23] . These observations parallel the much earlier observations by Recant and Riggs [19] in their nephrotic patients with low thyroid hormone levels in the absence of clinical hypothyroidism. Subsequently the interest in free 25(OH)D and free 1,25(OH) 2 D levels has increased substantially because of their relevance to disease states in which the binding proteins are markedly altered such as liver disease and protein losing nephropathy, normal physiologic states such as pregnancy, and genetic variations in binding proteins that may affect their affinity for the hormone in question [24] .
The bound, free and bioavailable fractions in serum.
In serum samples from normal individuals, ~85% of circulating vitamin D metabolites are bound to DBP, whereas albumin with its substantially lower binding affinity binds only ~15% of these metabolites despite its 10-fold higher concentration than DBP. Approximately 0.4% of total 1,25(OH) 2 D and 0.03% of total 25OHD is free in serum from normal non pregnant individuals. The fraction of "bioavailable" vitamin D metabolites is comprised of the fraction of the free vitamin D and the fraction bound to albumin, thus measuring around 15% in normal individuals. At this point there is little evidence that the albumin fraction is truly bioavailable, although because the albumin-hormone complexes generally dissociate rapidly this fraction may be more bioavailable in a dynamically perfused tissue [25] . That said our discussion will focus on the free fraction, although data examining the relationship of bioavailable 25(OH)D to clinical outcomes will also be considered.
The megalin/cubilin transport system. [26 27 ]. This complex is not specific for DBP, but when megalin is deleted, the major protein lost in the urine is DBP. In the mice that survive long enough bone growth is retarded and osteopenic [26] . The impact of cubilin deletion is similar but not as severe [27] . A similar mechanism may operate in the parathyroid gland and placenta, which like the renal tubule express megalin/cubilin [28] , but at this point experiments to determine the impact of either megalin or cubilin deletion from the parathyroid or gland or placenta have not been reported.
Assays and methods for assessing free vitamin D metabolite levels
Centrifugal ultrafiltration.
To test the free hormone hypothesis with respect to vitamin D metabolites, centrifugal ultrafiltration was developed to measure the free fraction of 25(OH)D and 1,25(OH) 2 D [29] [30] [31] [32] .
The original motivation was first to determine whether the low vitamin D metabolite levels in patients with liver disease truly indicated vitamin D deficiency. There was good reason to question this in that we and others had shown that patients with liver disease develop osteoporosis, not osteomalacia [33 34] , and generally do not respond to vitamin D supplementation [35 36 ] with respect to their bone disease. In addition, as mentioned earlier, both DBP and 1,25(OH) 2 D were known to increase during the latter portions of pregnancy, although 25(OH)D levels typically did not, raising the question as to whether the increased 1,25(OH) 2 D levels were a direct result of the increased DBP levels, or were the free levels also increased disproportionate to that of the total levels [22] . The latter was suggested by the increased intestinal calcium absorption during pregnancy [37] , a well-known physiologic target for 1,25(OH) 2 D (presumably free).
The centrifugal ultrafiltration assay for the vitamin D metabolites was patterned after the method developed by Hammond et al. [38] for the measurement of free sex steroid hormone levels. It consisted of an inner vial capped on one end with dialysis membrane resting on filter pads at the bottom of an outer vial. The serum sample, following incubation with freshly purified 2 D, so the ratio of total vitamin D metabolite to DBP levels was not predictive of the free level. Similarly, the directly measured free 25(OH)D (in this case by the ELISA method to be described subsequently) was higher than would be expected from the ratio of total 25(OH)D to DBP [39] . Thus during pregnancy it appears that the body has altered the affinity of DBP for the vitamin D metabolites to increase the free fraction. The mechanism for this is unknown.
However, as we will now discuss, this apparent change in affinity provides a challenge to the use of calculating the free concentration based on the assumption that the affinity constants do not change under physiologic conditions.
Calculating the free vitamin D metabolite levels.
Centrifugal ultrafiltration was used to determine the affinity constants for DBP and 
DBP and its assays
DBP is the major binding and transport protein for vitamin D and its metabolites. DBP is a 51-58 kDa multifunctional serum glycoprotein synthesized by hepatic parenchymal cells. DBP is found in plasma, ascites fluid, cerebrospinal fluid, and on the surface of many cell types. DBP is encoded by the single copy GC gene located on chromosome 4q12-q13 [44] and is a member of a multigene family that includes albumin, α-fetoprotein, and α-albumin/afamin [45] . Initially, isoelectric focusing migration patterns identified phenotypic variants [46] termed Group-Specific Component (Gc)1f, Gcs and Gc2 that bound vitamin D [47] . Subsequently the responsible genetic polymorphisms have been identified. Two common missense point mutations in exon 11 of SNPs rs7041 (G/T single-nucleotide variation) and rs4588 (an A/C single-nucleotide variation) result in three common isoforms and different protein products at positions 416 and 420: Gc1F (Asp416, Thr420), Gc1S (Glu 416, Thr420), and Gc2 (Asp416, Lys420) [48] . The SNPs are in complete linkage disequilibrium, and only six haplotypes are observed with any significant frequency (Table 1) . Gc2 is the least abundant and Gc1f the most abundant. Gc alleles show distinct racial distribution patterns. Black and Asian populations are more likely to carry the Gc1f form and the Gc2 form is rare, while Whites more frequently exhibit the Gc1s and the Gc2 form. Gc1f has been stated to have the highest affinity and Gc2 the lowest affinity for vitamin D and its metabolites [24] , but these differences among alleles have not been found by others [40] . In the absence of disease or pregnancy, DBP levels are relatively constant over time in adults [49] . That said, various substances in the blood such as polyunsaturated fatty acids may alter the affinity of DBP for the vitamin D metabolites [50] . Moreover, as noted previously liver disease leads to reduced levels of DBP [32] as do protein losing nephropathy [51] and acute illness (DBP is an acute phase reactant) [52 53 ], whereas DBP levels are elevated during the latter stages of pregnancy and with oral contraceptive use [22 29] . DBP is generally measured by immunoassays with either monoclonal or polyclonal antibodies. In 2013 Powe et al. [54] reported that, compared to white Americans, black Americans had similar levels of calculated bioavailable 25OHD despite lower levels of total 
LC-MS/MS method. LC-MS/MS has been used to detect 25(OH)D in saliva, which is
expected to be free of DBP and albumin and so represents free 25(OH)D [62] . In this method one ml of saliva is deproteinized with acetonitrile, purified using a Strata-X cartridge, derivatized with 4-phenyl-1,2,4-triazoline-3,5 dione (PTAD), ionized by electron spray ionization (ESI) and subjected to LC-MS/MS. The limit of detection was reported as 2 pg/ml, comparable to that of the ELISA method described above. The range of values obtained in normal controls was between 3-15 pg/ml, likewise consistent with the values obtained with the ELISA method [39] and centrifugal ultrafiltration [32] .
Thus armed with the means to measure free vitamin D metabolite levels, we turn our attention to whether measuring free levels provides a better means of assessing vitamin D status clinically than measuring the total levels.
Clinical Applications
Clinical studies have investigated relationships between calculated and directly measured free or bioavailable 25(OH)D and parathyroid hormone levels (iPTH), bone density, calcium and calcium absorption, inflammatory measures, and the disease states of cirrhosis, nephrotic syndrome, primary hyperparathyroidism, pregnancy, and in relationship to estrogens and birth control pills or race [40] . 
Effects of Race
There are differences in DBP levels and DBP alleles by race that might predict 
Effects of Obesity
Walsh, et al studied obese and overweight subjects compared to normal weight subjects in the fall and spring. BMI was negatively correlated with total 25(OH)D, free 25(OH)D, as well as total 1,25(OH) 2 D. However, obesity altered the relationship between iPTH with similar iPTH levels in all groups, but lower bone turnover markers and higher bone density in obese subjects [70] .
Effects of Sex, Female Hormones, and Pregnancy
Investigations have not found differences in free levels of 25(OH)D between men and women in those with prediabetes when corrected for total 25(OH)D [64] . Similarly, we have (Tables 2 and   3 and Figure 2 ). These results suggest that the affinity of DBP for the vitamin D metabolites appears to be decreased during pregnancy, perhaps compensating for increased DBP concentrations and the needs of both the mother and fetus for calcium. Whether this reflects the influence of changes in the hormonal milieu during pregnancy on DBP affinity is not known. ( Tables 2 and 3 
Effects of Liver Disease/ Cirrhosis
Effects of Multimorbidity
Nursing home residents are older, have more medical problems, receive more medications, and are more likely to have poorer nutrition than younger people or communitydwelling elderly. In vitamin D dose titration studies [68] , free 25(OH)D levels rise in response to increases in total 25(OH)D, but responses appear to be steeper than those of normal subjects, younger outpatients, diabetics, or HIV-infected patients ( Figure 2 ). It is likely that this reflects impaired protein synthesis and lower DBP and albumin, but this has not been established.
Summary/Conclusions
Direct measurement of free vitamin D metabolite levels avoids potential errors inherent 
